secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001493152-25-020072
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack adds Dr. Usman Latif to clinical advisory team for integrated glucose monitoring
--------------------------------------------------------------------------------

- Appoints Usman Latif, MD, MBA, a neuromodulation and PDN expert, to its clinical advisory team.
- Dr. Latif is Associate Professor at Kansas University Medical Center and board-certified anesthesiologist.
- Company aims to integrate glucose sensing into spinal cord stimulator leads for PDN patients.
- PDN affects ~1 in 5 Americans with diabetes, over 7 million people.
- Long-term preclinical study completed showing feasibility and safety of epidural glucose monitoring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225020072/0001493152-25-020072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225020072/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-020072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer